USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
APOLOGIC, INC.
Address:
APOLOGIC, INC.
3130 HIGHLAND AVE, STE 3265
CINCINNATI, OH 45219
Phone:
(513) 475-6664
URL:
N/A
EIN:
311487192
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $195,086.00 3
SBIR Phase II $474,176.00 1

Award List:

SCREENING FOR NOVEL ALZHEIMERS DISEASE DRUGS

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$95,086.00
Agency:
HHS
Principal Investigator:
Marques, Marcos A
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Marcos A. Marques
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$474,176.00
Agency:
HHS
Principal Investigator:
Marcos A. Marques
Abstract:
N/a

NOVEL TREATMENTS FOR ALZHEIMER'S DISEASE

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
The strategy proposed here for developing novel therapies for treating Alzheimer's disease is based on the finding that neurotoxic and amyloid-depositing fragments apolipoprotein E may play a role in this disease. This, in turn, suggests that degradation of this protein contributes to theā€¦ More